Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

被引:79
|
作者
Ulldemolins, Marta [1 ,2 ,3 ]
Roberts, Jason A. [2 ,4 ,5 ]
Lipman, Jeffrey [2 ,4 ]
Rello, Jordi [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Vall Hebron Univ Hosp, VHIR, Barcelona 08035, Spain
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] CIBERES, Barcelona, Spain
[4] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SEVERE SEPSIS; CLINICAL PHARMACOKINETICS; ANTIMICROBIAL THERAPY; GLOMERULAR-FILTRATION; ANTIBACTERIAL AGENTS; CREATININE CLEARANCE; HYPOALBUMINEMIA; PREDICTION;
D O I
10.1378/chest.10-2371
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although early and appropriate antibiotic therapy remains the cornerstone of success for the treatment of septic shock, few data exist to guide antibiotic dose optimization in critically ill patients, particularly those with multiple organ dysfunction syndrome (MODS). It is well known that MODS significantly alters the patient's physiology, but the effects of these variations on pharmacokinetics have not been reviewed concisely. Therefore, the aims of this article are to summarize the disease-driven variations in pharmacokinetics and pharmacodynamics and to provide antibiotic dosing recommendations for critically ill patients with MODS. The main findings of this review are that the two parameters that vary with greatest significance in critically ill patients with MODS are drug volume of distribution and clearance. Disease- and clinician-driven changes lead to an increased volume of distribution and lower-than-expected plasma drug concentrations during the first day of therapy at least. Decreased antibiotic clearance is common and can lead to drug toxicity. In summary, "front-loaded" doses of antibiotic during the first 24 11 of therapy should account for the likely increases in the antibiotic volume of distribution. Thereafter, maintenance dosing must be guided by drug clearance and adjusted to the degree of organ dysfunction. CHEST 2011; 139(5):1210-1220
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 50 条
  • [41] Thyrotoxicosis Factitia Leading to Multiple Organ Dysfunction Syndrome
    Rayasam, V.
    Haider, S.
    Mehta, A.
    Ladzinski, A.
    Patel, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [42] Thyroid storm presenting as multiple organ dysfunction syndrome
    Jiang, YZ
    Hutchinson, KA
    Bartelloni, P
    Manthous, CA
    CHEST, 2000, 118 (03) : 877 - 879
  • [43] Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome
    Watson, R. Scott
    Crow, Sheri S.
    Hartman, Mary E.
    Lacroix, Jacques
    Odetola, Folafoluwa O.
    PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 : S4 - S16
  • [44] Role of multiple organ dysfunction syndrome in ARDS mortality
    FS Dias
    N Almeida
    IC Wawrzeniack
    PB Nery
    Critical Care, 6 (Suppl 1):
  • [45] Ulcerative colitis and multiple organ dysfunction syndrome (MODS)
    Caprilli, R
    Latella, G
    INFLAMMATORY BOWEL DISEASE: A CLINICAL CASE APPROACH TO PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, 2002, 122 : 115 - 121
  • [46] The alteration of autonomic function in multiple organ dysfunction syndrome
    Schmidt, Hendrik
    Hoyer, Dirk
    Wilhelm, Joachim
    Soeffker, Gerold
    Heinroth, Konstantin
    Hottenrott, Kuno
    Said, Samir M.
    Buerke, Michael
    Mueller-Werdan, Ursula
    Werdan, Karl
    CRITICAL CARE CLINICS, 2008, 24 (01) : 149 - +
  • [47] Infection, the gut and the development of the multiple organ dysfunction syndrome
    Nieuwenhuijzen, GAP
    Deitch, EA
    Goris, RJA
    EUROPEAN JOURNAL OF SURGERY, 1996, 162 (04) : 259 - 273
  • [48] The Multiple Organ Dysfunction Syndrome: Syndrome, Metaphor, and Unsolved Clinical Challenge
    Marshall, John C.
    Deutschman, Clifford S.
    CRITICAL CARE MEDICINE, 2021, 49 (09) : 1402 - 1413
  • [49] Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome
    Gauvin, F
    Toledano, B
    Champagne, J
    Lacroix, J
    CRITICAL CARE MEDICINE, 2000, 28 (09) : 3341 - 3345